News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Evolution of HR+/HER2- breast cancer during exposure to neoadjuvant chemotherapy and endocrine treatment
Photo taken from Francesco Schettini/X
Jul 4, 2024, 14:15

Evolution of HR+/HER2- breast cancer during exposure to neoadjuvant chemotherapy and endocrine treatment

ESMO Open shared a post on X:

“Hot off the press: Francesco Schettini et al. analyze the clinical and biological evolution of HR+/HER2- breast cancer during exposure to neoadjuvant chemotherapy and endocrine treatment. ”

Image

Proceed to the article.
Source: ESMO Open/X

 

cancer endocrine treatment ESMO Open Francesco Schettini HR+/HER2- breast cancer neoadjuvant chemotherapy OncoDaily Oncology
Special Coverage
Blog
Oct 5, 2024, 11:04
Mazyar Shadman: Accepting application for BMT/Immunotherapy fellowship at Fred Hutchinson Cancer Center
Blog
Oct 5, 2024, 11:01
Why we need more basic scientists in supportive care and survivorship research - MASCC
Blog
Oct 5, 2024, 10:59
Zainab Shinkafi-Bagudu: Africa has a voice - Breaking down barriers
Blog
Oct 5, 2024, 10:59
Diogo Martins Branco: ESMO Reimbursement Model
Blog
Oct 5, 2024, 10:56
Carnell Jermaine Hampton: FMEA technique to investigate and improve the approach to Total Body Irradiation
Blog
Oct 5, 2024, 10:53
Chris Chukwunyere: Sharing Insights on Community-Based Participatory Research at the PRECISE Symposium
Blog
Oct 5, 2024, 10:39
Anna-Elina Rahikainen: Thank you IPOS for the opportunity to present
Blog
Oct 5, 2024, 09:50
Jashodeep Datta Named Principal Investigator for $2.5M NCI R37 MERIT Grant
Blog
Oct 5, 2024, 09:30
Medicaid expansion increased use of adjuvant therapy for NSCLC
Insight
Oct 5, 2024, 09:27
Patricia P. Falconer: Patients residing in rural communities have more barriers to care and a higher risk of financial toxicity
Blog
Oct 5, 2024, 09:26
Emily Holthuis: Expanding Partnerships with Patients and Carers in the EORTC
Blog
Oct 5, 2024, 09:24
Andreas Brandl: Prophylactic use of HIPEC in T4 colorectal cancer at ESSO43